Genzyme Corporation FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Apr 9, 2026
  • Last warning letter 2025
Inspections 27 2 OAI
Recalls 6 0 Class I (0%)
Warning letters 1 Latest Jan 15, 2025
510(k) clearances 33 Latest Dec 21, 2010

Genzyme Corporation has 6 FDA recalls, 27 inspections, 33 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Genzyme Corporation, the most recent on Jan 15, 2025. FDA has published 5 Form 483s for Genzyme Corporation.

What these totals cover: FDA records filed under the name "Genzyme Corporation" and its spelling variant "Genzyme". They do not include records filed under Sanofi or other names in its corporate family; those are listed under Related names, each with its own counts.

Latest recall
D-0362-2025 · Mar 26, 2025 · filed under Chattem
Latest recall under this name
D-0075-2018 · Class III · Oct 12, 2017
Latest inspection
Apr 9, 2026 · VAI
Latest 510(k)
Dec 21, 2010

Newer recall under related name Chattem: Mar 26, 2025, D-0362-2025.

Part of the Sanofi corporate family.

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls6Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026Current
510(k) clearances33Nov 22, 2026File dated Nov 18, 2026Current
Inspections27Nov 22, 2026Newest record Nov 9, 2026Current
Compliance actions1Nov 22, 2026Newest record Nov 13, 2026Current

FDA record by year

Genzyme Corporation's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Genzyme Corporation: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 1 inspection (1 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 2 inspections (0 OAI), 1 warning letter, 0 recall records (0 Class I) 2026: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202610000
202520100
202411000
202300000
202210000
202100000
202010000
201900000
201810000
201710010

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Genzyme Corporation as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Genzyme Corporation yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Genzyme Corporation FDA Warning Letters

1 warning letter on Jan 15, 2025.

IssuedSubjectIssuing officeClose-out letter
Jan 15, 2025 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Genzyme Corporation Form 483s

5 Form 483s published by FDA.

DateDocumentFEI
Apr 9, 2026 · Document on fda.gov 4831220423
Feb 14, 2025 · Document on fda.gov 4833009389940
Aug 30, 2024 · Document on fda.gov 4832246315
Jul 23, 2015 · Document on fda.gov 4831000305672
Jul 23, 2015 · Document on fda.gov 4831000305672

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent recalls

6 recall records from Jun 13, 2012 to Oct 12, 2017.

NumberClassProductDate
D-0075-2018Class IIIClolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva…Oct 12, 2017
D-0729-2016Class IIThyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular…Feb 16, 2016
D-0730-2016Class IIThyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular…Feb 16, 2016
D-0799-2016Class IIILumizyme (alglucosidase alpha), 50 mg/vial, For Intravenous Infusion Only, Rx Only, Manufactured by…Dec 8, 2015
Z-1856-2012Class IIseprafilm¿ Single Site ADHESION BARRIER Re-order Number: 6641-01 Product Usage: Seprafilm…Jun 13, 2012
Z-1855-2012Class IIseprafilm¿ Procedure Pack ADHESION BARRIER Re-order Number: 5086-02 Product Usage: Seprafilm…Jun 13, 2012

Recent FDA inspections

27 inspections from Oct 20, 2008 to Apr 9, 2026. Showing the 20 most recent. View all 27 inspections

DateSiteProductClassificationFEI
Apr 9, 2026Framingham, MADrugsVoluntary Action Indicated (VAI)1220423
Aug 14, 2025Northborough, MADrugsNo Action Indicated (NAI)3009389940
Feb 14, 2025Northborough, MABiologicsVoluntary Action Indicated (VAI)3009389940
Jul 9, 2024Framingham, MADrugsOfficial Action Indicated (OAI)1220423
Jul 25, 2022Framingham, MADrugsVoluntary Action Indicated (VAI)1220423
Feb 28, 2020Northborough, MADrugsNo Action Indicated (NAI)3009389940
Jul 19, 2018Northborough, MADrugsNo Action Indicated (NAI)3009389940
Feb 2, 2017Framingham, MADrugsNo Action Indicated (NAI)1220423
Aug 18, 2016Northborough, MADrugsVoluntary Action Indicated (VAI)3009389940
Aug 10, 2016Cambridge, MADrugsNo Action Indicated (NAI)1221955
Nov 21, 2014Framingham, MADrugsVoluntary Action Indicated (VAI)1220423
Sep 25, 2014Framingham, MADrugsVoluntary Action Indicated (VAI)1220423
Sep 18, 2014Northborough, MADrugsNo Action Indicated (NAI)3009389940
Aug 22, 2014Cambridge, MADrugsNo Action Indicated (NAI)1221955
Mar 25, 2014Cambridge, MADrugsNo Action Indicated (NAI)1221955
Sep 30, 2013Cambridge, MADrugsVoluntary Action Indicated (VAI)1221955
Apr 9, 2013Northborough, MADevicesNo Action Indicated (NAI)3009389940
Oct 5, 2012Cambridge, MADrugsNo Action Indicated (NAI)1221955
Jul 13, 2012Framingham, MADrugsVoluntary Action Indicated (VAI)1220423
Feb 17, 2012Northborough, MADrugsNo Action Indicated (NAI)3009389940
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Genzyme Corporation: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Jan 15, 2025.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

4 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 1220423Framingham, MA9Apr 9, 2026
FEI 3009389940Northborough, MA8Aug 14, 2025
FEI 1221955Cambridge, MA9Aug 10, 2016
FEI 3003984125Oxford, United Kingdom1Aug 6, 2009

Recent 510(k) clearances

33 510(k) clearances from May 22, 1991 to Dec 21, 2010. Showing the 20 most recent. View all 33 510(k) clearances

K-NumberDeviceDate
K102242OSOM C. DIFFICILE TOXIN A/B TESTDec 21, 2010
K092633OSOM INFLUENZA A&B TEST , MODEL PN190Sep 25, 2009
K080662GENZYME CYSTATIN C REAGENT ANF GENZYME CYSTATIN C CALIBRATORMay 15, 2008
K063739SEPRAMESH, MODEL 5959-1214Jan 17, 2007
K061508OSOM INFLUENZA A&B TESTJun 12, 2006
K051244GENZYME OSOM INFLUENZA A & B TESTFeb 21, 2006
K053066SEPRAMESH IP BIORESORBABLE COATING/PERMANENT MESHDec 19, 2005
K043035SEPRAGEL ENT BIORESORBABLE PACKING/STENTJul 11, 2005
K040241N-GENEOUS WIDE RANGE CRP REAGENT AND CALIBRATOR SETJun 25, 2004
K040868SEPRAMESH IP BIORESORBABLE BARRIER - PERMANENT MESHJun 4, 2004
K033864GENZYME OSOM TRICHOMONAS RAPID TESTApr 2, 2004
K023544GENZYME CONTRAST II HCG URINE/SERUM TESTJan 16, 2003
K021316ULTRA N-GENEOUS HDL CHOLESTEROL REAGENT 1/REAGENT2; ULTRA N-GENEOUS HDL CHOLESTREOL CALIBRATORJul 25, 2002
K021019COTTONY II, SILKY II POLYDEK & TEVDEK II POLYESTER SUTUREJun 18, 2002
K012532SEPRAGEL SINUSOct 30, 2001
K011843GENZYME DIRECT-AMYLASE TEST REAGENTAug 10, 2001
K000239GLYPRO REAGENT, GLYPRO CALIBRATOR, GLYPRO LOW CONTROL, GLYPRO HIGH CONTROLMar 21, 2000
K994328SEPRAMESH BIOSURGICAL COMPOSITE, MODEL SMBC-XXXMar 2, 2000
K992766N-GENEOUS LDL-ST CHOLESTEROL REAGENT, N-GENEOUS LDL-ST CHOLESTEROL CALIBRATOR, GENZYME LDL…Oct 18, 1999
K993132GENZYME DIRECT AMYLASE VERIFIEROct 4, 1999

Genzyme Corporation and the FDA: common questions

Has Genzyme Corporation received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Genzyme Corporation. The most recent is dated Jan 15, 2025.

Has Genzyme Corporation received an FDA Form 483?

FDA has published 5 Form 483s for Genzyme Corporation in its reading room, the most recent dated Apr 9, 2026. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Genzyme Corporation?

The most recent FDA inspection on file ended Apr 9, 2026 at Framingham, MA and was classified VAI. FDA has 27 inspections of Genzyme Corporation on file, 2 of them classified OAI (official action indicated).

Has Genzyme Corporation had an FDA recall?

Yes. Genzyme Corporation has 6 FDA recalls on record. The most recent under this name started Oct 12, 2017. A newer recall, dated Mar 26, 2025, is filed under the related name Chattem.

Need more than this page shows? Ask about Genzyme Corporation in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.